Welcome to our dedicated page for First Trust Financials AlphaDEX® ETF news (Ticker: FXO), a resource for investors and traders seeking the latest updates and insights on First Trust Financials AlphaDEX® ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect First Trust Financials AlphaDEX® ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of First Trust Financials AlphaDEX® ETF's position in the market.
First Trust Financials AlphaDEX Fund (NASDAQ: FXO) has become the second-largest shareholder of Freedom Holding Corp. (NASDAQ: FRHC), following its acquisition of 185,000 shares. The investment makes FXO the largest institutional investor after CEO Timur Turlov, with FRHC now representing a 1.22% weighting in the fund's underlying index.
The investment highlights Freedom Holding's strong fundamentals and growth potential. S&P Global Ratings has revised the outlook for FRHC's core subsidiaries from "Stable" to "Positive" while maintaining their 'B+/B' credit ratings. The parent company's rating remains at 'B-' with a Stable outlook. Additionally, the Stanford Graduate School of Business has included FRHC as its first Central Asian case study.
FAQ
What is the current stock price of First Trust Financials AlphaDEX® ETF (FXO)?
